Access cutting-edge acute pancreatitis treatment through this clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Access acute pancreatitis specialists in Memphis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute pancreatitis treatment provided free
This is a phase I/II clinical trial assessing the tolerability and efficacy of CM4620 in children and young adults with acute pancreatitis caused by asparaginase. The tolerability of CM4620 when given to patients receiving frontline chemotherapy will be determined. The effectiveness in reducing the severity of pancreatitis will be estimated. Primary Objectives To assess the safety of CM4620 administration in children and young adults with asparaginase associated pancreatitis (AAP). To profile
Sponsor: St. Jude Children's Research Hospital
Check if you qualify for this acute pancreatitis clinical trial in Memphis, TN
If you're searching for acute pancreatitis treatment options in Memphis, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute pancreatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.